AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Epimmune Provides HIV Vaccine Program Update.(Brief Article)
2001 OCT 10 - (NewsRx.com & NewsRx.net) --
Epimmune Inc., presenting at the AIDS Vaccine 2001 Conference held in Philadelphia, Pennsylvania, September 7, 2001, provided additional information on its HIV vaccine program including its initial vaccine candidate and clinical trial plans.
Epimmune anticipates that it will file an Investigational New Drug (IND) application for its initial vaccine candidate, a therapeutic HIV vaccine, in the first quarter of 2002. Clinical trials could begin approximately one month later, pending FDA review. They stated that a pre-IND meeting was previously held in August 2001 with U.S. Food and Drug Administration (FDA) staff and representatives of the U.S. National Institutes of Health (NIH), Division of AIDS, a program sponsor.
The initial clinical trials, which are supported by an NIH grant, will be conducted at the University of Colorado Health Services Center under the direction of Constance Benson, MD and Cara Wilson, MD, and will involve approximately 40 infected ...
- GenVec and NIH Move HIV Vaccine Candidate Into Human Clinical Trials.
- Press release article from: PR Newswire July 28, 2004 700+ words
...clinical study to test an HIV vaccine candidate developed utilizing GenVec...NIAID and will employ HIV vaccine candidates produced by...advancement in the field of HIV vaccine development. This unique vaccine candidate is being developed for...
- HIV vaccine candidate into human clinical trials.
- Newspaper article from: Gene Therapy Weekly August 26, 2004 700+ words
...immunodeficiency virus) vaccine candidate developed...will employ HIV vaccine candidates...field of HIV vaccine development. This unique vaccine candidate is being...This vaccine candidate has the potential...of planned HIV vaccine trials ...
- Chiron's HIV Vaccine Candidate Begins Clinical Trial in United States; Trial...
- Press release article from: PR Newswire January 15, 2004 700+ words
...United States for its HIV vaccine candidate. The trial, the result...collaboration between the HIV Vaccine Trials Network (HVTN...vaccine. "Chiron's vaccine candidate represents a novel approach to HIV vaccine development, and we...
- IAVI Begins First Phase II Preventive HIV Vaccine Trial in South Africa to Test...
- Press release article from: Business Wire November 14, 2005 700+ words
...tgAAC09, a preventive HIV vaccine candidate that is based on...the first Phase II HIV vaccine trial to be held...approved its first HIV vaccine trials in 2003...of this promising vaccine candidate while supporting...
- Epimmune's HIV Vaccine Candidate Taken by the National Institutes of Health and...
- Press release article from: PR Newswire April 7, 2003 700+ words
...ideal setting to evaluate our HIV vaccine candidate." "The HVTN welcomes the...speeding progress toward an HIV vaccine and controlling the global pandemic...inventors." The EP HIV-1090 vaccine candidate is composed of DNA that has...
- Merck's Investigational HIV Vaccine Candidate to be Studied In Collaborative...
- Press release article from: Business Wire September 19, 2003 700+ words
...clinical trial of Merck's HIV vaccine candidate in 18 cities around the world...is the first study of an HIV vaccine candidate to take place in so many...testing their investigational HIV vaccine candidate on a truly global scale...
- HIV vaccine candidate trial begins in 18 cities around the world.
- Newspaper article from: Immunotherapy Weekly October 15, 2003 700+ words
...clinical trial of Merck's HIV vaccine candidate in 18 cities around the world...is the first study of an HIV vaccine candidate to take place in so many...testing their investigational HIV vaccine candidate on a truly global scale...
- HIV vaccine candidate taken by into phase I trial in U.S., Africa.
- Newspaper article from: Virus Weekly May 6, 2003 700+ words
...ideal setting to evaluate our HIV vaccine candidate." "The HVTN welcomes the...speeding progress toward an HIV vaccine and controlling the global pandemic...inventors." The EP HIV-1090 vaccine candidate is composed of DNA that has...
